XTX Topco’s Takeda Pharmaceutical TAK Stock Holding History

XTX Topco’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-71,324	Closed	-$1.32M	–	4692
2026 Q1	$1.32M	Sell	71,324 -152	-0.2%	-$2.67K	0.02%	1184
2025 Q4	$1.11M	Buy	71,476 +58,183	+438%	+$832K	0.03%	954
2025 Q3	$195K	Buy	+13,293	New	+$197K	0.01%	1859
2025 Q1	–	Sell	-24,492	Closed	-$324K	–	3086
2024 Q4	$324K	Sell	24,492 -42,794	-64%	-$588K	0.03%	1155
2024 Q3	$957K	Buy	+67,286	New	+$954K	0.07%	442
2024 Q2	–	Sell	-42,116	Closed	-$585K	–	2451
2024 Q1	$585K	Buy	+42,116	New	+$612K	0.08%	397
2023 Q3	–	Sell	-19,329	Closed	-$304K	–	1997
2023 Q2	$304K	Buy	+19,329	New	+$317K	0.05%	711
2022 Q3	–	Sell	-11,208	Closed	-$157K	–	1376
2022 Q2	$157K	Buy	+11,208	New	+$160K	0.06%	527

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

XTX Topco's TAK Position: Q2 2026 in Review

XTX Topco sold out of Takeda Pharmaceutical (TAK) in Q2 2026, closing a stake of 71,324 shares — an estimated $1.32M sold.

XTX Topco first reported a position in TAK in Q2 2022 and held it in 8 quarters. The position peaked at $1.32M in Q1 2026. 378 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

XTX Topco reported no remaining Takeda Pharmaceutical position as of Q2 2026 after selling out during the quarter.
XTX Topco sold 71,324 Takeda Pharmaceutical shares in Q2 2026, an estimated $1.32M.
XTX Topco first reported a position in Takeda Pharmaceutical in Q2 2022 and held it in 8 quarters.
XTX Topco's Takeda Pharmaceutical position peaked at $1.32M in Q1 2026.
378 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.